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Medicinal plants (e.g. Discaria americana) have been used by populations for centuries. However, popular 
use is not enough to validate these plants as safe and effective medicinal products. The present study 
sought to evaluate the acute and subacute toxicity as well as the anxiolytic and antinociceptive effects of 
D. americana root bark and aerial parts extracts in mice. In acute toxicity studies, mice were treated with 
single intraperitoneal doses of the aforementioned extracts. Subacute toxicity studies were performed by 
oral administration of the extracts over 14 days. Anxiolytic studies consisted of the elevated plus maze 
method, and antinociceptive studies were based on the hot plate test. The LD50 value for D. americana 
aerial parts extract was established at >500 mg/kg, and for the root bark extract, 400 mg/kg. D. americana 
aerial parts extract produced anxiolytic (250 mg/kg) and antinociceptive effects (125, 200 and 250 mg/kg). 
Conversely, D. americana root bark extract showed neither anxiolytic nor antinociceptive effects in mice.
Descriptors: Discaria americana/phamacognosy. Medicinal plants. Discaria americana/toxicological 
analysis. Discaria americana/acute toxicity. Discaria americana/subacute toxicity. Discaria americana/
anxiolytic effect. Discaria americana/antinociceptive effect.
As plantas medicinais (i. e. Discaria americana) têm sido utilizadas pela população por séculos, entretanto, 
o conhecimento popular não é suficiente para validá-las como medicamentos seguros e/ou efetivos. Assim, 
o presente estudo teve por objetivo avaliar a toxicidade aguda e subaguda, bem como o efeito ansiolítico 
e antinociceptivo dos extratos da casca da raiz e das partes aéreas da D. americana em camundongos. A 
toxicidade aguda foi avaliada pela administração dos extratos, via intraperitoneal. Para o estudo da toxicidade 
subaguda os animais foram tratados oralmente com os extratos por 14 dias. O efeito ansiolítico dos extratos 
foi determinado através do modelo do labirinto em cruz elevado e o efeito antinociceptivo, mediante o teste da 
placa quente. O valor da DL50 para o extrato das partes aéreas da D. americana foi definido como > 500 mg/kg,  
enquanto que para o extrato da casca da raiz foi estabelecido em 400 mg/kg. O extrato das partes aéreas da 
D. americana apresentou atividade ansiolítica (250 mg/kg) e antinociceptiva (125, 200 e 250 mg/kg). O 
extrato da casca da raiz da D. americana não apresentou efeito ansiolítico nem antinociceptivo.
Unitermos: Discaria americana/farmacognosia. Palntas medicinais. Discaria americana/análise 
toxicológica. Discaria americana/toxicidade aguda. Discaria americana/toxicidade subaguda. Discaria 
americana/efeito ansiolítico. Discaria americana/efeito antinociceptivo.
INTRODUCTION
Medicinal plants have been used by populations for 
centuries. Even now, many plants play a key role in world 
health (Calixto, 2000). However, popular use is not enough 
to validate these plants as safe and effective medicines 
(Agra et al., 2007). Toxicity studies are required to evalu-
ate the toxicity levels and adverse effects associated with 
medicinal plants. In addition to toxicity studies, study of the 
pharmacological activity of these plants is also important.
Discaria americana Gillies & Hook is a shrub 
from the Rhamnaceae family. This plant is known by the 
common names “Quina-do-Brasil” and “Quina-do-Rio-
Grande” (Brazil) or “Coronillo del campo” and “Quina 
del campo” (Uruguay) (Correa, 1984). D. Americana root 
bark is used by local populations against stomach and 
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skin diseases, diabetes, fever (antipyretic), and as a tonic 
(Záchia, Moraes, 1999). However, almost no studies have 
assessed the toxicological and pharmacological properties 
of this plant; only one report, describing strong antioxidant 
activity of the essential oil extracted from the aerial parts 
of D. americana (Rodriguez, Murray, 2008), was located 
by a review of the literature.
The main chemical constituents of D. americana are 
pentacyclic triterpenes and steroids (Giacomelli, 2005). An 
important point is the presence of the triterpene ursolic acid, 
which has showed antioxidant (Ramachandram, Prasad, 
2008), antinociceptive, anti-inflammatory (Tapondjou et al., 
2003) and anti-cancer activities (Shao et al., 2011). The ste-
roid b-sitosterol showed antioxidant (Yokota et al., 2006), 
antinociceptive (Cechinel Filho, Yunes, 1998), anti-cancer 
(Jourdain et al., 2006) and anti-inflammatory effects (Vale-
rio, Awad, 2011). Furthermore, betulinic acid, a triterpene, 
has known anti-cancer, antinociceptive, anti-inflammatory, 
anti-HIV and antimicrobial activities (Yogeeswari, Sriram, 
2005), as well as anxiolytic effects (Durst et al., 2002).
Cyclopeptide alkaloids and cyclopeptides (Gia-
comelli et al., 2004; Giacomelli, 2005) have also been 
isolated from D. americana. However, almost nothing has 
been reported on the toxic and pharmacological effects 
of these compounds. Among the alkaloids, frangulanine 
has a sedative effect, whereas discarine A and discarine B 
reportedly show antibacterial activity (Maldaner, 2005).
Some Rhamnaceae plants have been reported to 
show high levels of toxicity and adverse effects. Liver and 
lung damage and death have been observed in mice given 
Karwinskia humboldtiana (Bermudez et al., 1986). This 
plant also caused a decrease in ATP levels in the kidney 
and blood (Jaramillo-Juárez et al., 2005) and central ner-
vous system damage in rats (Becerra-Verdin et al., 2009). 
Rhamnus cathartica, another plant from the same family, 
is known to be hepatotoxic in mice (Lichtensteiger et al., 
1997). Therefore, according to the toxicity shown by other 
Rhamnaceae, evaluation of the toxicity of D. americana 
is paramount.
Thus, the present study sought to evaluate the acute 
and subacute toxicity of D. americana aerial parts and 
root bark extracts, as well as the potential anxiolytic and 
antinociceptive effects of these extracts, in mice.
MATERIAL AND METHODS
Plant material
D. americana root bark and aerial parts were col-
lected in Jaguari, RS, Brazil (29° 49′ 70″ S, 54° 69′ 00″ 
W) and authenticated by Dr. Renato Záchia, Department of 
Botany, Universidade Federal de Santa Maria, RS, Brazil, 
where a specimen sample (SMDB 2688) is retained.
Chemicals
Dimethyl sulfoxide (DMSO) and methanol (MeOH) 
were obtained from VETEC Química Fina LTDA® (Rio de 
Janeiro, RJ, Brazil). Kits for clinical chemistry analysis of 
aspartate aminotransferase (AST) and alanine aminotrans-
ferase (ALT) were obtained from Labtest Diagnóstica S/
A® (Lagoa Santa, MG, Brazil). Paracetamol was obtained 
from Labsynth® (Diadema, SP, Brazil). Diazepam (DZP) 
was obtained from União Química Farmacêutica Nacional 
S/A® (Jabaquara, SP, Brazil).
Preparation and identification of D. americana 
extracts
Dried ground root bark (1080 g) and aerial parts 
(1200 g) of D. americana were extracted with methanol 
(MeOH) (6 L) in a Soxhlet apparatus for 12 h. The result-
ing MeOH extracts were filtered and concentrated under 
vacuum, yielding the crude residues of the plant root bark 
and aerial parts (2.79 and 0.69% yield, respectively). The 
extracts were dissolved in dimethyl sulfoxide (DMSO) for 
administration in mice.
Four cyclopeptides were isolated from the root bark 
of D. americana (discarene C, discarene D, discarine M 
and discarine N), as well as nine cyclopeptide alkaloids 
(adoutine Y, adoutine Y′, franganine, frangulanine, disca-
rine A, discarine B, discarine C, discarine D and myrian-
thine A), betulinic acid, and three steroids (b-sitosterol, 
b-sitosterol-3-O-6-b-D-glucopyranoside and b-sitoster-
ol-3-O-6-stearoyl-b-D-glucopyranoside). The steroids 
b-sitosterol and b-sitosterol-3-O-6-b-D-glucopyranoside, 
three pentacyclic triterpenes (betulinic acid, ursolic acid 
and ceanotic acid) and an ester derived from ferulic acid 
were isolated from the plant aerial parts. The isolated 
compounds were identified by direct comparisons with au-
thentic samples by thin layer chromatography (TLC) and 
on the basis of NMR spectral data. TLC was performed on 
precoated silica gel 60 F254 plates (Merck®) (mobile phase: 
mixture of CHCl3 and MeOH) and detection was achieved 
by UV light (254 nm), by spraying with Dragendorff’s 
reagent, and by spraying with 10 % H2SO4, followed by 
heating (Giacomelli et al., 2004; Giacomelli, 2005).
Animals
Healthy mice (Mus musculus) of either sex (1:1), 
weighing 35-45 g, obtained from our own breeding fa-
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cilities, were kept in an air-conditioned room (22 ± 2 oC), 
under a 12-hour light/dark cycle (lights on at 8:00 a.m.), 
with water and food (Nuvital® chow, PR, Brazil) 
ad libitum. A total sample of 270 mice was used for toxic-
ity and pharmacology studies. For each test, animals were 
divided into groups of 10 animals. The experiments were 
carried out with the approval of the Universidade Regional 
Integrada do Alto Uruguai e das Missões Research Ethics 
Committee (protocol no. 023/07).
Acute toxicity studies
Groups of 10 mice were injected with single doses 
of D. americana root bark extract (50, 100, 300, 400 and 
500 mg/kg), plant aerial parts extract (500 mg/kg) and 
DMSO (control). The dose of 500 mg/kg was established 
as the highest dose of the plant extract for determination of 
LD50. Mice were injected intraperitoneally, as this route of 
administration is associated with rapid absorption, thus en-
abling evaluation of exposure during a short period of time.
Signs of general toxic effects, such as weight loss, 
seizures, or death, were observed continuously for 2 h and 
then monitored over a 48-hour period. After 48 h, animals 
were euthanized and necropsied for gross observation of 
the heart, kidneys and liver, as well as blood sample collec-
tion. The study was carried out as by Maciel et al. (2000), 
with the exception of exposure time (48 hours).
Subacute toxicity studies
D. americana root bark extract (50 and 100 mg/kg) 
and aerial parts extract (300 and 400 mg/kg) were admin-
istered to groups of 10 mice by once-daily gavage for 14 
days. Control group animals received the vehicle (DMSO) 
under the same conditions. Toxic manifestations, such as 
seizures, weight loss, and death, were monitored daily. At 
the end of the 14-day period, animals were euthanized and 
necropsied for macroscopic observation of the heart, kid-
neys and liver, as well as blood sample collection. Again, 
the study was carried out as by Maciel et al. (2000), except 
for the route of administration.
Blood analysis
Blood was collected in heparinized tubes and 
used immediately. Tubes were centrifuged at 3000 rpm 
for 10 min to obtain serum, which was then analyzed. 
Transaminase (AST and ALT) activity was determined 
enzymatically as described by Bergmeyer (1978), using 
commercial kits from Labtest Diagnóstica S. A® in a semi-
automatic LABQUEST® biochemical analyzer.
Evaluation of anxiolytic effect
The elevated plus maze (EPM) method was used 
to assess the anxiety level of mice. The maze consists 
of two opposed open arms and two opposed enclosed 
arms, bounded by 30-cm high walls. Each arm measures 
50 x 10 cm, with a shared central area of 10 x 10 cm. The 
maze is kept 50 cm above the floor.
Single doses of D. americana root bark extract 
(50, 100 and 200 mg/kg), aerial parts extract (125 and 
250 mg/kg), DMSO (placebo control) and diazepam 
1.5 mg/kg (positive control) were administered intraperi-
toneally to groups of 10 mice.
One hour after treatment, mice were placed on the 
central area of the maze. The number of entries into the en-
closed and open arms was recorded, as was the time spent 
in each arm. Time spent in the open arms was considered 
as the measure of anxiolytic effect (Pellow et al., 1985).
Evaluation of antinociceptive effect 
The experiment started 60 min (time zero) after 
intraperitoneal administration of D. americana root bark 
extract (50, 100 and 200 mg/kg) and aerial parts extract 
(125, 200 and 250 mg/kg) to groups of 10 mice. Animals 
were placed individually on a hot plate kept at a constant 
temperature of 55 °C. The time to first paw lick (henceforth 
“latency”) was recorded. Measurements were performed 
at 0, 15, 30 and 60 min after the first thermal stimulus. To 
avoid damage to the animals’ paws, the maximum time 
spent on the plate was 30 s. Therefore, a latency period 
of 30 s was defined as complete antinociception (Ankier, 
1974). For comparison, the same experiment was con-




To assess acute toxicity of D. americana, mice were 
injected with aerial parts and root bark extracts and with 
DMSO (control). During the experiment, the occurrence 
of adverse affects and the mortality of mice were observed. 
The maximum dose of 500 mg/kg of D. americana aerial 
parts extract did not cause death in mice; hence, the LD50 
value was established as >500 mg/kg (Table I). 
According to Saraswat et al. (1996), ursolic acid, 
a triterpene constituent of D. americana, has hepatopro-
tective activity. However, acute administration of the 
plant aerial parts extract at the dose of 500 mg/kg caused 
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a significant increase in transaminase (ALT and AST) 
levels (Table II). High serum levels of these enzymes are 
a marker of injury, usually liver damage. Furthermore, 
autopsy of these animals revealed a variable number (1 
to 4) of opalescent oval lesions, approximately 0.5 cm in 
diameter, on the liver. These hepatic lesions were observed 
in 70% of animals. 
Acute administration of D. americana root bark 
extract caused mortality proportional to the administered 
doses. At the highest dose level (500 mg/kg), the mortality 
rate was 60%. The LD50 was established as 400 mg/kg. At 
this dose, there was a significant increase in AST levels. 
At 300 mg/kg, 40% of mice died, and half of those that 
survived showed evidence of liver injury and significantly 
increased ALT levels. At the dose of 50 and 100 mg/kg, 
there was no mortality, but ALT levels were increased as 
compared to mice in the control group.
The weight of mice that survived acute exposure 
was evaluated 48 h after administration of the extracts. 
There was no significant weight loss in mice treated with 
D. americana extracts as compared to the control group. 
Furthermore, there was no significant difference in liver 
weight/body weight of mice treated with D. americana in 
relation to the control group (Table III).
No macroscopic changes were observed in the kid-
neys and hearts of mice treated with D. americana extracts. 
Furthermore, there was no significant difference in kidney 
weight or heart weight/body weight of mice treated with 
D. americana in relation to the control group. No seizure 
activity was observed in acute toxicity studies. There were 
no deaths or adverse effects in the control group.
Subacute toxicity
For assessment of subacute toxicity, D. americana 
extracts and DMSO were orally administered to mice for 
TABLE I - Effect of acute and subacute administration of D. 
americana extracts on mortality in mice. N =10
Treatments Dose (mg/kg) Mortality (%)
Acute toxicity
Control - 0.0





Aerial parts extract 500 0.0
Subacute toxicity
Control - 0.0
Root bark extract 50 10.0
100 20.0
Aerial parts extract 300 0.0
400 20.0
TABLE II - Effect of acute administration of D. americana 






Control - 52.4 ± 6.8 363.6 ± 28.6
Root bark 
extract
50 104.4 ± 33.6* 359.2 ± 57.9
100 145.7 ± 6.9* 364.0 ± 40.9
300 186.0 ± 38.5* 348.7 ± 41.8
400 - 516.0 ± 80.4*
Aerial parts 
extract 500 101.4 ± 34.9** 425.8 ± 60.4**
Values are expressed as mean ± standard deviation. N= 4-10.
(*) Statistically different from controls, p<0.05 (ANOVA/
Tukey’s test). (**) Student’s t test.
TABLE III - Effect of acute and subacute D. americana exposure 









Control - 105.2 ± 7.3 5.01 ± 0.90
Root bark extract
50 95.0 ± 3.0 4.90 ± 0.23
100 93.0 ± 6.0 5.64 ± 1.40
300 90.6 ± 9.6 5.85 ± 0.87
400 92.9 ± 2.5 6.37 ± 0.37
500 88.0 ± 8.0 5.61 ± 0.13
Aerial parts extract 500 93.0 ± 8.1 5.27 ± 0.79
Subacute toxicity
Control - 104.0 ± 5.2 5.10 ± 0.49
Root bark extract
50 97.8 ± 4.4 4.86 ± 0.41
100 91.5 ± 5.7* 5.30 ± 0.80
Aerial parts extract
300 105.2 ±7.3 4.84 ± 0.52
400 91.6 ± 7.2* 5.00 ± 0.61
Values are expressed as mean ± standard deviation. N= 4-10.
(*) Statistically different from controls, p<0.05 (ANOVA/
Tukey’s test).
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14 days. General toxic effects and mortality were observed 
during the treatment period. At a dose of 400 mg/kg, the 
aerial parts extract caused 20% mortality (Table I), mod-
erate weight loss (Table III), and a significant increase in 
ALT and AST levels (Table IV). At 300 mg/kg, there were 
no deaths or significant weight loss, although ALT and 
AST levels did increase.
At a dose of 100 mg/kg, D. americana root bark 
extract led to significant weight loss and increased ALT 
and AST levels, as well as a 20% mortality rate. A dose of 
50 mg/kg was associated with 10% mortality and increased 
serum AST levels, but no significant weight loss.
The greater toxicity of D. americana root bark 
extract as compared to the aerial parts extract can be at-
tributed to the alkaloids present in the root bark. A review 
of the literature showed that some of these alkaloids have 
known toxic effects in mice (Tabosa et al., 2006). Further-
more, some alkaloids are toxic – mainly hepatotoxi – in 
humans (Bolzan et al., 2007).
No macroscopic changes were observed in the liver, 
kidneys and heart of mice treated with D. americana ex-
tracts. There were no significant differences in the ratio of 
weight of these organs to body weight in mice treated with 
D. americana as compared to the control group. No seizure 
activity was observed in subacute toxicity studies. There 
were no deaths and no adverse effects in the control group.
Although important parameters were evaluated in 
these acute and subacute toxicity studies, further assess-
ments are needed before intake of D. americana can be 
considered safe in humans. 
Pharmacology
This study evaluated the anxiolytic effect of D. 
americana in mice using the elevated plus maze (EPM) 
method. The potential antinociceptive effect of the plant 
was evaluated with the hot plate test. No toxic doses or 
doses that showed lower toxicity effects were used in the 
pharmacology portion of this study. These doses were de-
termined according to acute toxicity studies. For D. ameri-
cana root bark extract, 50 mg/kg (1/8 LD50), 100 mg/kg 
(1/4 LD50) and 200 mg/kg (1/2 LD50) doses were used. 
The aerial parts extract of D. americana showed a LD50 
of >500 mg/kg. At this dose, toxic manifestations were 
observed; therefore, half of this dose (250 mg/kg) was 
used for pharmacology studies. The 125 and 200 mg/kg 
doses were also used in pharmacological studies in order 
to evaluate the possibility of a dose-dependent effect.
In the anxiolytic studies, the control group spent 
most of the 10 min in the enclosed arms of the EPM, in-
dicating anxiety. Data showed an increase in time spent 
in the open arms among mice treated with D. americana 
aerial parts extract at the dose of 250 mg/kg. This reduc-
tion in anxiety could be associated with ursolic acid, an 
important component of the aerial parts of D. americana 
that has known anxiolytic properties (Durst et al., 2002). 
A similar effect occurred in the positive control group 
(DZP 1.5 mg/kg). D. americana root bark extract had no 
anxiolytic effect (Table V).
Antinociceptive studies revealed that mice treated 
with D. americana aerial parts extract at a dose of 
125 mg/kg had a significant reduction in nociceptive 
response at 0 and 15 s. The 200 mg/kg dose caused a 
significant increase in latency at all periods analyzed. At 
a 250 mg/kg dose, the nociceptive response was > 30 s. 
A trend toward dose-dependent increase in the analgesic 
effect of D. americana aerial parts extract was observed. 
This striking antinociceptive potential of D. americana 
TABLE IV - Effect of subacute administration of D. americana 
extracts on serum transaminase levels (U/L) in mice
Treatments Dose (mg/kg) ALT (SGPT) AST (SGOT)
Control - 88.7 ± 18.2 360.2 ± 65.7
Root bark extract
50 119.0 ± 25.7 482.1 ± 46.3*
100 169.3 ± 40.2* 491.5 ± 31.0*
Aerial parts extract
300 128.8 ± 33.7* 493.8 ± 72.8*
400 191.4 ± 43.4* 516.0 ± 33.2*
Values are expressed as mean ± standard deviation. N= 8-10.
(*) Statistically different from controls, p<0.05 (ANOVA/
Tukey’s test).
TABLE V - Time spent in open arms of the elevated plus maze 
after exposure to D. americana extracts
Treatments Dose (mg/kg) Time spent in open arms (%)
Control - 23.0 ± 7.4
Root bark extract
50 42.2 ± 12.8
100 37.8 ± 14.5
200 42.6 ± 13.7
Aerial parts extract
125 39.1 ± 13.8
250 72.0 ± 18.1*
Diazepam 1.5 81.8 ± 22.8*
Values are expressed as mean ± standard deviation. N=10.
(*) Statistically different from controls, p<0.05 (ANOVA/
Tukey’s test).
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can be ascribed to three components that are present in the 
plant: the triterpenes ursolic acid (Tapondjou et al., 2003) 
and betulinic acid (Yogeeswari, Sriram, 2005) and the 
steroid b-sitosterol (Cechinel Filho, Yunes, 1998), which 
are known antinociceptive agents. Pretreatment of animals 
with paracetamol (400 mg/kg), the positive control used in 
this study, also caused a significant antinociceptive effect 
(nociceptive response >30 s). Conversely, D. americana 
root bark extract did not reduce the nociceptive response 
in mice (Table VI).
In conclusion, the present study showed that D. 
americana root bark extract produces toxic effects at low 
doses and was not successful as an anxiolytic or antino-
ciceptive agent. Conversely, an aerial parts extract of the 
same plant showed low toxicity even when administered 
at the highest doses, and successfully reduced anxiety 
and nociception in mice. However, to protect human 
health, further toxicity studies are necessary if this plant 
is to be used as a herbal remedy. On the basis of the find-
ings reported herein, D. americana can be considered a 
promising source for development of new anxiolytic and 
analgesic agents.
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